Short-Term Versus Long-Term Efficacy of Endoscopic Sleeve Gastroplasty in 8880 Obese Patients: A Systematic Review and Meta-Analysis.
A comprehensive analysis of nearly 9,000 patients confirms that minimally invasive gastric procedures produce meaningful weight loss, offering an alternative for people who cannot tolerate or access other treatments.
This meta-analysis of 8,880 obese patients comprehensively evaluates the short- and long-term weight loss outcomes of endoscopic sleeve gastroplasty, establishing the largest pooled evidence base for this minimally invasive procedure. As obesity remains the central driver of cardiometabolic morbidity, ESG evidence consolidation is relevant to GLP-1 and surgical comparator landscapes.
What the study was
- Study design
- Systematic review and meta-analysis
- Population
- Obese adult patients undergoing endoscopic sleeve gastroplasty
- Sample size
- 8880
- Category
- Treatment Innovation
- Maturity
- Validated
- Journal
- Diabetes Obesity & Metabolism
Why it surfaced
Largest published meta-analysis of ESG efficacy; relevant to GLP-1/cardiometabolic watchlist as comparative weight-loss intervention benchmark. Diabetes Obes Metab is a well-regarded specialist journal.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.